Leukotriene B4 ethanolamide

Leukotriene B4 ethanolamide

• CAS Number: 877459-63-7
• UNSPSC Description: Leukotriene B4 ethanolamide (LTB4 ethanolamide) is an antagonist and a partial agonist for Leukotriene B4 (LTB4) receptor 1 (BLTR1). Leukotriene B4 ethanolamide ameliorates the tumor progression, which is only asscociated with inflammation[1][2].
• Target Antigen: Endogenous Metabolite; Leukotriene Receptor
• Type: Reference compound
• Related Pathways: GPCR/G Protein;Metabolic Enzyme/Protease
• Applications: Cancer-programmed cell death
• Field of Research: Cancer
• Assay Protocol: https://www.medchemexpress.com/leukotriene-b4-ethanolamide.html
• Solubility: 10 mM in DMSO
• Smiles: CCCCC/C=C\C[C@@H](O)/C=C/C=C/C=C\[C@@H](O)CCCC(NCCO)=O
• Molecular Weight: 379.53
• References & Citations: [1]McHugh D, et al., Novel compounds that interact with both leukotriene B4 receptors and vanilloid TRPV1 receptors. J Pharmacol Exp Ther. 2006 Feb;316(2):955-65.|[2]Bachi AL, et al., Leukotriene B4 creates a favorable microenvironment for murine melanoma growth. Mol Cancer Res. 2009 Sep;7(9):1417-24.
• Shipping Conditions: Room temperature
• Clinical Information: No Development Reported